• Intellia Therapeutics (NASDAQ:NTLA) Price Target Cut to $68.00 by Analysts at Chardan Capital

    Source: Buzz FX / 01 Mar 2025 11:06:14   America/New_York


    Intellia Therapeutics (NASDAQ:NTLA) Price Target Cut to $68.00 by Analysts at Chardan Capital Written by MarketBeat March 1, 2025 Share Link copied to clipboard. Intellia Therapeutics ( NASDAQ:NTLA - Get Free Report ) had its price target d
    Read more...
Share on,